Literature DB >> 7982726

Release of monokines by pulmonary macrophages following antigen challenge in sensitized guinea pigs.

M Denis1, D E Kelly, D F Biggs.   

Abstract

Guinea pigs were passively sensitized with immune serum to ovalbumin (OA), control serum, or saline. Twenty-four hours later, they inhaled aerosols of OA (2% in saline), saline, or lipopolysaccharide (LPS). Following anesthesia, bronchoalveolar lavage (BAL) was performed at 30, 60, 90 and 120 min postinhalation. Alveolar macrophages (AM) were isolated from the BAL fluid and incubated (18 h) in medium alone or with zymosan (1 mg/ml). Supernatants were collected and levels of interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) determined by bioassays. Unstimulated AM from animals that inhaled OA, saline, or LPS secreted similar amounts of IL-1 at 30, 60, and 90 min postinhalation. Zymosan (1 mg/ml) significantly increased IL-1 secretion by AM collected at 60 and 90 min from OA-sensitized animals that inhaled OA or saline. AM from guinea pigs sensitized to OA that inhaled OA or LPS secreted significantly increased amounts of IL-6 at 30, 60, 90, and 120 min postchallenge compared to saline sensitized controls. In all groups, AM from LPS-treated animals secreted large amounts of TNF-alpha at all sampling times postchallenge; AM from OA-sensitized and challenged animals secreted increasing amounts of TNF-alpha with time postchallenge, spontaneously and in response to zymosan. By contrast, AM from saline sensitized and challenged guinea pigs did not release detectable amounts of TNF-alpha spontaneously and secreted very low amounts in the presence of zymosan. These findings show that antigen challenge results in a rapid activation of AM isolated from BAL and suggest AM may initiate the development of inflammatory processes associated with antigen challenge.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982726     DOI: 10.1007/BF01534433

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  37 in total

1.  Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.

Authors:  C Dubois; E Bissonnette; M Rola-Pleszczynski
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

2.  Enhanced alveolar cell luminol-dependent chemiluminescence in asthma.

Authors:  M Cluzel; M Damon; P Chanez; J Bousquet; A Crastes de Paulet; F B Michel; P Godard
Journal:  J Allergy Clin Immunol       Date:  1987-08       Impact factor: 10.793

Review 3.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

Review 4.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Recombinant human IL-1 alpha and -1 beta potentiate IgE-mediated histamine release from human basophils.

Authors:  W A Massey; T C Randall; A Kagey-Sobotka; J A Warner; S M MacDonald; S Gillis; A C Allison; L M Lichtenstein
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

6.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Authors:  D Aderka; J M Le; J Vilcek
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

7.  Late appearance of phospholipid platelet-activating factor and leukotriene B4 in human skin after repeated antigen challenge.

Authors:  M Shalit; F H Valone; P C Atkins; W D Ratnoff; E J Goetzl; B Zweiman
Journal:  J Allergy Clin Immunol       Date:  1989-03       Impact factor: 10.793

8.  Airway eosinophils from actively sensitized guinea pigs exhibit enhanced superoxide anion release in response to antigen challenge.

Authors:  F Cerasoli; J Tocker; W M Selig
Journal:  Am J Respir Cell Mol Biol       Date:  1991-04       Impact factor: 6.914

9.  Inhibition of antigen-induced airway hyperresponsiveness, but not acute hypoxia nor airway eosinophilia, by an antagonist of platelet-activating factor.

Authors:  K Ishida; R J Thomson; L L Beattie; B Wiggs; R R Schellenberg
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

10.  Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity.

Authors:  R W Fuller; P K Morris; R Richmond; D Sykes; I M Varndell; D M Kemeny; P J Cole; C T Dollery; J MacDermot
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.